Toxoplasmosis Differential Diagnoses
- Author: Murat Hökelek, MD, PhD; Chief Editor: Burke A Cunha, MD more...
Diagnostic Considerations
Conditions to consider in the differential diagnosis of congenital toxoplasmosis include rubella, encephalopathies, and erythroblastosis fetalis. In the differential diagnosis of toxoplasmic encephalitis, vasculitis and tumor should be considered. The major differential diagnosis of focal CNS lesions in patients with AIDS is CNS lymphoma, which manifests as multiple enhancing lesions in 40% of cases.
Other differentials in the diagnosis of toxoplasmosis include the following:
- Other lesions caused by Cryptococcus neoformans, Aspergillus species , Mycobacterium tuberculosis, Nocardia species
- Mycosis fungoides
- Pneumocystis (carinii) jiroveci pneumonia
- Sarcoidosis
- Bacterial sepsis
- Syphilis
- Tuberculosis
- Tularemia
- Acute HIV infection
- Cytomegalovirus retinitis
- Cytomegalovirus encephalitis
- Cytomegalovirus ventriculitis
- CNS tuberculosis
- Disseminated tuberculosis
- Leukemia
- Lymphoma
- Progressive multifocal leukoencephalopathy
- Acute retinal necrosis
- Fungal endophthalmitis
- Epimacular membrane
- Intraocular foreign body
- Uveitic glaucoma
- Ocular manifestations of HIV
- Ocular manifestations of syphilis
- Anterior granulomatous uveitis
- Anterior nongranulomatous uveitis
- Fuchs heterochromic uveitis
- Toxocariasis
- Primary intraocular lymphoma
- Pars planitis
Differential Diagnoses
- Brain Abscess
- Catscratch Disease
- Cytomegalovirus
- Herpes Simplex
- Histoplasmosis
- Infectious Mononucleosis
- Leprosy
- Listeria Monocytogenes
- Lymphoma, Lymphoblastic
- Metastatic Cancer, Unknown Primary Site
Lindsay DS, Dubey JP. Toxoplasma gondii: the changing paradigm of congenital toxoplasmosis. Parasitology. Sep 9 2011;1-3. [Medline].
Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. Jun 12 2004;363(9425):1965-76. [Medline].
[Guideline] Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. Apr 10 2009;58:1-207; quiz CE1-4. [Medline].
Jones JL, Kruszon-Moran D, Sanders-Lewis K, Wilson M. Toxoplasma gondii infection in the United States, 1999 2004, decline from the prior decade. Am J Trop Med Hyg. Sep 2007;77(3):405-10. [Medline].
Martin AM, Liu T, Lynn BC, Sinai AP. The Toxoplasma gondii parasitophorous vacuole membrane: transactions across the border. J Eukaryot Microbiol. Jan-Feb 2007;54(1):25-8. [Medline].
Phan L, Kasza K, Jalbrzikowski J, Noble AG, Latkany P, Kuo A, et al. Longitudinal study of new eye lesions in children with toxoplasmosis who were not treated during the first year of life. Am J Ophthalmol. Sep 2008;146(3):375-384. [Medline]. [Full Text].
Freeman K, Tan HK, Prusa A, Petersen E, Buffolano W, Malm G, et al. Predictors of retinochoroiditis in children with congenital toxoplasmosis: European, prospective cohort study. Pediatrics. May 2008;121(5):e1215-22. [Medline].
Latkany P. Ocular Disease Due to Toxoplasma gondii. In: Weiss LM, Kim K, eds. Toxoplasma gondii the Model Apicomplexan: Perspectives and Methods. London, United Kingdom: Academic Press; 2007:101-31.
Villard O, Filisetti D, Roch-Deries F, Garweg J, Flament J, Candolfi E. Comparison of enzyme-linked immunosorbent assay, immunoblotting, and PCR for diagnosis of toxoplasmic chorioretinitis. J Clin Microbiol. Aug 2003;41(8):3537-41. [Medline]. [Full Text].
Nagineni CN, Detrick B, Hooks JJ. Toxoplasma gondii infection induces gene expression and secretion of interleukin 1 (IL-1), IL-6, granulocyte-macrophage colony-stimulating factor, and intercellular adhesion molecule 1 by human retinal pigment epithelial cells. Infect Immun. Jan 2000;68(1):407-10. [Medline]. [Full Text].
Yamamoto JH, Vallochi AL, Silveira C, Filho JK, Nussenblatt RB, Cunha-Neto E, et al. Discrimination between patients with acquired toxoplasmosis and congenital toxoplasmosis on the basis of the immune response to parasite antigens. J Infect Dis. Jun 2000;181(6):2018-22. [Medline].
Cordeiro CA, Moreira PR, Costa GC, Dutra WO, Campos WR, Oréfice F, et al. Interleukin-1 gene polymorphisms and toxoplasmic retinochoroiditis. Mol Vis. 2008;14:1845-9. [Medline]. [Full Text].
Cordeiro CA, Moreira PR, Andrade MS, Dutra WO, Campos WR, Oréfice F, et al. Interleukin-10 gene polymorphism (-1082G/A) is associated with toxoplasmic retinochoroiditis. Invest Ophthalmol Vis Sci. May 2008;49(5):1979-82. [Medline].
Cordeiro CA, Moreira PR, Costa GC, Dutra WO, Campos WR, Oréfice F, et al. TNF-alpha gene polymorphism (-308G/A) and toxoplasmic retinochoroiditis. Br J Ophthalmol. Jul 2008;92(7):986-8. [Medline].
Montoya JG, Remington JS. Toxoplasmic chorioretinitis in the setting of acute acquired toxoplasmosis. Clin Infect Dis. Aug 1996;23(2):277-82. [Medline].
Gras L, Wallon M, Pollak A, Cortina-Borja M, Evengard B, Hayde M, et al. Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres. Acta Paediatr. Dec 2005;94(12):1721-31. [Medline].
Thiébaut R, Leproust S, Chêne G, Gilbert R. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data. Lancet. Jan 13 2007;369(9556):115-22. [Medline].
Luft BJ, Remington JS. Toxoplasmic encephalitis in AIDS. Clin Infect Dis. Aug 1992;15(2):211-22. [Medline].
Porter SB, Sande MA. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med. Dec 3 1992;327(23):1643-8. [Medline].
Torok E, Moran E, Cooke F. Toxoplasmosis. In: Oxford Handbook of Infectious Diseases and Microbiology. Vol 1. New York: Oxford University Press; 2009:567.
Hofman P, Bernard E, Michiels JF, Thyss A, Le Fichoux Y, Loubière R. Extracerebral toxoplasmosis in the acquired immunodeficiency syndrome (AIDS). Pathol Res Pract. Sep 1993;189(8):894-901. [Medline].
Smith RE, Ganley JP. Ophthalmic survey of a community. 1. Abnormalities of the ocular fundus. Am J Ophthalmol. Dec 1972;74(6):1126-30. [Medline].
Desmonts G, Couvreur J. Congenital toxoplasmosis. A prospective study of 378 pregnancies. N Engl J Med. May 16 1974;290(20):1110-6. [Medline].
McCannel CA, Holland GN, Helm CJ, Cornell PJ, Winston JV, Rimmer TG. Causes of uveitis in the general practice of ophthalmology. UCLA Community-Based Uveitis Study Group. Am J Ophthalmol. Jan 1996;121(1):35-46. [Medline].
Glasner PD, Silveira C, Kruszon-Moran D, Martins MC, Burnier Júnior M, Silveira S, et al. An unusually high prevalence of ocular toxoplasmosis in southern Brazil. Am J Ophthalmol. Aug 15 1992;114(2):136-44. [Medline].
de-la-Torre A, López-Castillo CA, Gómez-Marín JE. Incidence and clinical characteristics in a Colombian cohort of ocular toxoplasmosis. Eye (Lond). May 2009;23(5):1090-3. [Medline].
Holland GN, Crespi CM, ten Dam-van Loon N, Charonis AC, Yu F, Bosch-Driessen LH, et al. Analysis of recurrence patterns associated with toxoplasmic retinochoroiditis. Am J Ophthalmol. Jun 2008;145(6):1007-1013. [Medline].
Remington JS. Toxoplasmosis in the adult. Bull N Y Acad Med. Feb 1974;50(2):211-27. [Medline]. [Full Text].
McCabe RE, Brooks RG, Dorfman RF, Remington JS. Clinical spectrum in 107 cases of toxoplasmic lymphadenopathy. Rev Infect Dis. Jul-Aug 1987;9(4):754-74. [Medline].
Monnet D, Averous K, Delair E, Brézin AP. Optical coherence tomography in ocular toxoplasmosis. Int J Med Sci. 2009;6(3):137-8. [Medline]. [Full Text].
Benevento JD, Jager RD, Noble AG, Latkany P, Mieler WF, Sautter M, et al. Toxoplasmosis-associated neovascular lesions treated successfully with ranibizumab and antiparasitic therapy. Arch Ophthalmol. Aug 2008;126(8):1152-6. [Medline]. [Full Text].
Ben Yahia S, Herbort CP, Jenzeri S, Hmidi K, Attia S, Messaoud R, et al. Intravitreal bevacizumab (Avastin) as primary and rescue treatment for choroidal neovascularization secondary to ocular toxoplasmosis. Int Ophthalmol. Aug 2008;28(4):311-6. [Medline].
Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, Miller EN, et al. HIV-associated neurologic disease incidence changes:: Multicenter AIDS Cohort Study, 1990-1998. Neurology. Jan 23 2001;56(2):257-60. [Medline].
Frenkel JK. Toxoplasmosis. Pediatr Clin North Am. Aug 1985;32(4):917-32. [Medline].
Dodds EM, Holland GN, Stanford MR, Yu F, Siu WO, Shah KH, et al. Intraocular inflammation associated with ocular toxoplasmosis: relationships at initial examination. Am J Ophthalmol. Dec 2008;146(6):856-65.e2. [Medline].
Ashburn D, Chatterton JM, Evans R, Joss AW, Ho-Yen DO. Success in the toxoplasma dye test. J Infect. Jan 2001;42(1):16-9. [Medline].
Lappalainen M, Hedman K. Serodiagnosis of toxoplasmosis. The impact of measurement of IgG avidity. Ann Ist Super Sanita. 2004;40(1):81-8. [Medline].
Levy RM, Mills CM, Posin JP, Moore SG, Rosenblum ML, Bredesen DE. The efficacy and clinical impact of brain imaging in neurologically symptomatic AIDS patients: a prospective CT/MRI study. J Acquir Immune Defic Syndr. 1990;3(5):461-71. [Medline].
Sobrin L, Kump LI, Foster CS. Intravitreal clindamycin for toxoplasmic retinochoroiditis. Retina. Sep 2007;27(7):952-7. [Medline].
Soheilian M, Ramezani A, Azimzadeh A, Sadoughi MM, Dehghan MH, Shahghadami R, et al. Randomized trial of intravitreal clindamycin and dexamethasone versus pyrimethamine, sulfadiazine, and prednisolone in treatment of ocular toxoplasmosis. Ophthalmology. Jan 2011;118(1):134-41. [Medline].
Soheilian M, Sadoughi MM, Ghajarnia M, Dehghan MH, Yazdani S, Behboudi H, et al. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis. Ophthalmology. Nov 2005;112(11):1876-82. [Medline].

